Trevi Therapeutics (TRVI) Q4 2025 Earnings

13NovConfirmed
Q1 2025
Q2 2025
Q3 2025
Q4 2025
-0.13
-0.11
-0.1
-0.08

Details

Expected EPS
-0.098317
Actual EPS
-0.08
Surprise EPS
0.02
Surprise Percent
+18.63%

Description

Trevi Therapeutics (TRVI) has reported earnings of -0.08 per share for Q4 2025.

0 Comments

Share your thoughts